Ir J Med Sci 2020 Feb 01
Diagnostic yield of a custom-designed multi-gene cancer panel in Irish patients with breast cancer.
McVeigh ÚM, McVeigh TP, Curran C, Miller N, Morris DW, Kerin MJ
Breast cancer is genetically heterogeneous, and parellel multi-gene sequencing is the most cost- and time-efficient manner to investigate breast cance ...
Read More
Source: PubMed
Eur J Oncol Nurs
Breast cancer patients' experiences of adherence and persistence to oral endocrine therapy: A qualitative evidence synthesis.
Clancy C, Lynch J, OConnor P, Dowling M
Adjuvant endocrine therapy (AET) significantly reduces the risk of breast cancer recurrence and mortality in women with hormone receptor (HR+) breast ...
Read More
Source: PubMed
Clin. Biochem. 2020 Jan 30
Current immunoassay methods and their applications to clinically used biomarkers of breast cancer.
Jeong S, Park MJ, Song W, Kim HS
Breast cancer is the leading cause of cancer-related mortality worldwide, with a higher incidence in developed countries. The biomarkers for breast ca ...
Read More
Source: PubMed
Int. J. Radiat. Oncol. Biol. Phys. 2020 Jan 29
Association Between Polymorphisms in DNA Damage Repair Genes and Radiation Therapy-Induced Early Adverse Skin Reactions in a Breast Cancer Population: A Polygenic Risk Score Approach.
Lee E, Eum SY, Slifer SH, Martin ER, Takita C, Wright JL, Hines RB, Hu JJ
Genetic variations in DNA damage repair (DDR) genes may influence radiation therapy (RT)-induced acute normal tissue toxicity in patients with breast ...
Read More
Source: PubMed
Ann Chir Plast Esthet 2020 Jan 29
[Comparing outcomes of Immediate Breast reconstruction with and without use of radiotherapy].
Julien L, Genet J, Leymarie N, Honart JF, Rimareix F, Mazouni C, Kolb F, De Frémicourt K, Conversano A, Marchal F, Simon E, Brix M, Sarfati B
Breast cancer and its treatment remains a public health problem. There is still a lack of epidemiological data concerning complications and aesthetic ...
Read More
Source: PubMed
